Kailera Therapeutics, Inc. — Investor Relations & Filings
Kailera Therapeutics, Inc. is a clinical-stage biotechnology company focused on advancing the next era of obesity care. The company develops a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its pipeline, designed with an obesity-first focus, includes four clinical-stage product candidates that leverage multiple GLP-1-based mechanisms of action and routes of administration. Kailera aims to provide diverse treatment options for individuals living with obesity, addressing critical needs within the current therapeutic landscape. Its lead program is a dual-action gut hormone receptor agonist.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-26 | English | |
| 8-K | 2026-05-26 | English | |
| Major Shareholding Notification 2026 | 2026-04-24 | English | |
| Major Shareholding Notification 2026 | 2026-04-24 | English | |
| 8-K | 2026-04-20 | English | |
| 424B4 | 2026-04-17 | English |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47073902 | 10-Q | 2026-05-26 | English | ||
| 47073261 | 8-K | 2026-05-26 | English | ||
| 46725211 | Major Shareholding Notification 2026 | 2026-04-24 | English | ||
| 46725212 | Major Shareholding Notification 2026 | 2026-04-24 | English | ||
| 46725214 | 8-K | 2026-04-20 | English | ||
| 46725220 | 424B4 | 2026-04-17 | English | ||
| 46725223 | S-8 | 2026-04-17 | English | ||
| 46725224 | Regulatory Filings 2026 | 2026-04-17 | English | ||
| 46725225 | S-1MEF | 2026-04-17 | English | ||
| 46725226 | Regulatory Filings 2026 | 2026-04-15 | English | ||
| 46725228 | 8-A12B | 2026-04-14 | English | ||
| 46725232 | S-1/A | 2026-04-13 | English | ||
| 46725237 | S-1 | 2026-03-27 | English | ||
| 46725239 | Regulatory Filings 2026 | 2026-02-11 | English | ||
|
2025
1 filing
| |||||
| 46725242 | Regulatory Filings 2025 | 2025-12-19 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
Kailera Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72610/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72610 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72610 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72610 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72610}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Kailera Therapeutics, Inc. (id: 72610)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.